Get the Stockscreener App
3.88
10.19%
-0.44
After Hours:
4.20
0.32
+8.25%
Achieve Life Sciences Inc stock is traded at $3.88, with a volume of 1.04M.
It is down -10.19% in the last 24 hours and down -22.40% over the past month.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
See More
Previous Close:
$4.32
Open:
$4.32
24h Volume:
1.04M
Relative Volume:
0.73
Market Cap:
$198.29M
Revenue:
-
Net Income/Loss:
$-32.94M
P/E Ratio:
-3.4955
EPS:
-1.11
Net Cash Flow:
$-24.95M
1W Performance:
-15.28%
1M Performance:
-22.40%
6M Performance:
+19.02%
1Y Performance:
-9.87%
1-Day Range:
$3.87
$4.435
1-Week Range:
$3.87
$4.67
52-Week Range:
$1.84
$5.78
Achieve Life Sciences Inc Stock (ACHV) Company Profile
Name
Achieve Life Sciences Inc
Sector
Industry
Phone
425-686-1500
Address
22722 29TH DR. SE, SEATTLE, BC
Compare ACHV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACHV
Achieve Life Sciences Inc
|
3.88 | 229.97M | 0 | -32.94M | -24.95M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.32 | 106.82B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.00 | 73.86B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.79 | 60.87B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.50 | 56.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
199.64 | 43.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-21-25 | Initiated | H.C. Wainwright | Buy |
| Nov-14-24 | Initiated | Rodman & Renshaw | Buy |
| Sep-27-24 | Initiated | Raymond James | Strong Buy |
| May-10-23 | Reiterated | Maxim Group | Buy |
| Jun-23-21 | Initiated | Oppenheimer | Outperform |
Achieve Life Sciences Inc Stock (ACHV) Latest News
Why Achieve Life Sciences Inc. stock could outperform in 2025July 2025 Technicals & Verified Swing Trading Watchlists - newser.com
Can Achieve Life Sciences Inc. (SP4P) stock sustain institutional flows2025 Technical Patterns & Free Fast Entry Momentum Trade Alerts - newser.com
What earnings margins imply for Achieve Life Sciences Inc. (SP4P) stockEarnings Beat & Safe Entry Zone Identification - newser.com
Achieve Life Sciences (NASDAQ:ACHV) Stock Price Crosses Above 200-Day Moving AverageHere's Why - MarketBeat
Will Achieve Life Sciences Inc. (SP4P) stock justify high valuationRecession Risk & Accurate Buy Signal Notifications - newser.com
Can Achieve Life Sciences Inc. stock maintain growth trajectoryTrade Exit Summary & Risk Controlled Stock Alerts - newser.com
What dividend safety score for Achieve Life Sciences Inc. stockForecast Cut & Weekly Consistent Profit Watchlists - newser.com
Is Achieve Life Sciences Inc. (SP4P) stock a fit for income portfoliosInsider Selling & Reliable Breakout Forecasts - newser.com
Can Achieve Life Sciences Inc. stock withstand economic slowdownJuly 2025 Gainers & Weekly High Return Forecasts - newser.com
Is Achieve Life Sciences Inc. (SP4P) stock a momentum leaderWeekly Market Report & Capital Efficiency Focused Ideas - newser.com
Is Achieve Life Sciences Inc. stock a buy for dividend growthMarket Movers & Advanced Swing Trade Entry Plans - newser.com
Will Achieve Life Sciences Inc. stock return to pre crisis levels2025 Major Catalysts & Long Hold Capital Preservation Plans - newser.com
Why Achieve Life Sciences Inc. (SP4P) stock gets analyst attentionWeekly Trading Summary & Consistent Return Investment Signals - newser.com
Can Achieve Life Sciences Inc. stock deliver strong Q4 earningsEarnings Growth Report & Stepwise Swing Trade Plans - newser.com
Is Achieve Life Sciences Inc. stock entering bullish territoryEarnings Miss & High Return Trade Opportunity Guides - newser.com
What insider trading reveals about Achieve Life Sciences Inc. stockMarket Movement Recap & Safe Entry Momentum Tips - newser.com
Is Achieve Life Sciences Inc. (SP4P) stock nearing a technical breakout2025 Market Sentiment & Smart Investment Allocation Tips - newser.com
Is Achieve Life Sciences Inc. stock near bottom after declineJuly 2025 Selloffs & Fast Entry and Exit Trade Plans - newser.com
When is the best time to exit Achieve Life Sciences Inc.July 2025 Short Interest & Fast Moving Stock Watchlists - newser.com
Is Achieve Life Sciences Inc. (SP4P) stock included in top ETFsJuly 2025 Macro Moves & Weekly Consistent Profit Watchlists - newser.com
How to recover losses in Achieve Life Sciences Inc. stockJuly 2025 Short Interest & Weekly Top Gainers Alerts - newser.com
Will Achieve Life Sciences Inc. stock continue dividend increasesGDP Growth & Community Verified Trade Signals - newser.com
Why Achieve Life Sciences Inc. (SP4P) stock could outperform next yearPortfolio Performance Summary & Risk Controlled Swing Alerts - newser.com
How analysts revise price targets for Achieve Life Sciences Inc. (SP4P) stockMarket Performance Report & Daily Stock Momentum Reports - newser.com
Why Achieve Life Sciences Inc. stock could rally in 2025Market Growth Review & AI Driven Price Forecasts - newser.com
Is Achieve Life Sciences Inc. (SP4P) stock a defensive play amid uncertaintyJuly 2025 Selloffs & Verified Trade Idea Suggestions - newser.com
Achieve Life Sciences Inc Stock (ACHV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.67%
0.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):